In the HealthTech market we tracked 103 deals so far in the first half of 2021. Private Equity activity in the market, which has been steadily increasing over the last 10 years, made up a third of all deals this year so far.
Disclosed M&A deal value has been rising from 2013 through 2018, followed by a precipitous drop in 2019. 2020, however, jumped to $34.1B spent. Despite the lower number of deals in 2021, disclosed M&A deal value in the first half beat all annual records jumping to a record high of $40.5B.
In terms of top acquirers of HealthTech, seven of the top 10 buyers were PE firms. Clearlake Capital led the pack, scoring 7 acquisitions, with The Carlyle Group and Constellation close behind. There were 2 strategic buyers on the leaderboard – CloudMD and Well Health - with 6 deals each. And Abry Partners, New Mountain Capital, and Thoma Bravo tied at 5 acquisitions each.